tiprankstipranks
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market

Kairos Pharma, Ltd. (KAPA) Income Statement

Compare
46 Followers

Kairos Pharma, Ltd. Income Statement

Last quarter (Q3 2024), Kairos Pharma, Ltd.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Kairos Pharma, Ltd.'s net income was $-1.05M. See Kairos Pharma, Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.71M$ 571.00K$ 1.94M$ 1.05M
Depreciation and Amortization
$ 160.00K$ 160.00K$ 98.00K$ -58.00
EBITDA
$ -1.55M$ -431.00K$ -1.88M$ -1.05M
Operating Income
$ -1.71M$ -571.00K$ -1.94M$ -1.05M
Other Income/Expenses
$ -98.00K$ -479.00K$ -202.00K$ -5.47K
Pretax Income
$ -1.81M$ -1.05M$ -2.15M$ -1.05M
Net Income
$ -1.81M$ -1.05M$ -2.15M$ -1.05M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -0.17$ -0.10$ -0.17$ -0.09
Diluted EPS
$ -0.17$ -0.10$ -0.17$ -0.09
Weighted Average Shares Outstanding
10.38M 10.24M 12.84M 11.22M
Weighted Average Shares Outstanding (Diluted)
10.38M 10.24M 12.84M 11.22M
Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis